Literature DB >> 27854217

Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.

Edwardo Ramos1, José G Conde2, Rafael Arias Berrios1, Sherly Pardo3, Omar Gómez1, Manuel F Mas Rodríguez1.   

Abstract

BACKGROUND: Duchenne and Becker Muscular Dystrophy (DMD and BMD, respectively), are common forms of inherited muscle disease. Information regarding the epidemiology of these conditions, including genotype, is still sparse.
OBJECTIVE: To establish the prevalence and genetic profile of DMD and BMD in Puerto Rico.
METHODS: We collected data from medical records in all Muscular Dystrophy Association (MDA) clinics in Puerto Rico in order to estimate the prevalence of DMD and BMD and to describe the genotypic profile of these patients. Patients selected for data analysis matched "definite", "probable" and "possible" case definitions as established by MD STARnet.
RESULTS: A total of 141 patients matched the inclusion criteria, with 64.5% and 35.5% being categorized into DMD and BMD, respectively. DMD and BMD prevalence in Puerto Rico was estimated at 5.18 and 2.84 per 100,000 males, respectively. Deletion was the most common form of mutation (66.7%) in the dystrophin gene, with exons in segment 45 to 47 being the most frequently affected.
CONCLUSIONS: This is the first report of the prevalence and genetic profile characteristics of DMD and BMD in Puerto Rico. Prevalence of DMD was similar to that reported worldwide, while prevalence of BMD was higher. Genetic profile was consistent with that reported in the literature.

Entities:  

Keywords:  Becker muscular dystrophy; Duchenne muscular dystrophy; Puerto Rico; dystrophinopathy; muscular dystrophy

Mesh:

Substances:

Year:  2016        PMID: 27854217      PMCID: PMC5117109          DOI: 10.3233/JND-160147

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  21 in total

1.  DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene.

Authors:  Luciana C B Dolinsky; Rodrigo S de Moura-Neto; Daisy Neves Falcão-Conceição
Journal:  Neuromuscul Disord       Date:  2002-11       Impact factor: 4.296

2.  alpha-Actinins and the DMD protein contain spectrin-like repeats.

Authors:  M D Davison; D R Critchley
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

3.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

Authors:  J T Den Dunnen; P M Grootscholten; E Bakker; L A Blonden; H B Ginjaar; M C Wapenaar; H M van Paassen; C van Broeckhoven; P L Pearson; G J van Ommen
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

4.  Duplications in the DMD gene.

Authors:  S J White; A Aartsma-Rus; K M Flanigan; R B Weiss; A L J Kneppers; T Lalic; A A M Janson; H B Ginjaar; M H Breuning; J T den Dunnen
Journal:  Hum Mutat       Date:  2006-09       Impact factor: 4.878

5.  Protein sequence of DMD gene is related to actin-binding domain of alpha-actinin.

Authors:  R G Hammonds
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

Review 6.  A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.

Authors:  Jean K Mah; Lawrence Korngut; Jonathan Dykeman; Lundy Day; Tamara Pringsheim; Nathalie Jette
Journal:  Neuromuscul Disord       Date:  2014-03-22       Impact factor: 4.296

7.  Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide.

Authors:  Carolyn H Buzin; Jinong Feng; Jin Yan; William Scaringe; Qiang Liu; Johan den Dunnen; Jerry R Mendell; Steve S Sommer
Journal:  Hum Mutat       Date:  2005-02       Impact factor: 4.878

8.  Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-16       Impact factor: 17.586

Review 9.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

10.  Online self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefits.

Authors:  Richard T Wang; Cheri A Silverstein Fadlon; J Wes Ulm; Ivana Jankovic; Ascia Eskin; Ake Lu; Vanessa Rangel Miller; Rita M Cantor; Ning Li; Robert Elashoff; Anne S Martin; Holly L Peay; Nancy Halnon; Stanley F Nelson
Journal:  PLoS Curr       Date:  2014-10-17
View more
  7 in total

1.  Genotype-phenotype correlation in Becker muscular dystrophy in Chinese patients.

Authors:  Ruiyi Yuan; Junfei Yi; Zhiying Xie; Yimeng Zheng; Miao Han; Yue Hou; Zhaoxia Wang; Yun Yuan
Journal:  J Hum Genet       Date:  2018-07-05       Impact factor: 3.172

Review 2.  Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.

Authors:  Salvatore Crisafulli; Janet Sultana; Andrea Fontana; Francesco Salvo; Sonia Messina; Gianluca Trifirò
Journal:  Orphanet J Rare Dis       Date:  2020-06-05       Impact factor: 4.123

3.  Exonic rearrangements in DMD in Chinese Han individuals affected with Duchenne and Becker muscular dystrophies.

Authors:  Chao Ling; Yi Dai; Li Fang; Fengxia Yao; Zhe Liu; Zhengqing Qiu; Liying Cui; Fan Xia; Chen Zhao; Shuyang Zhang; Kai Wang; Xue Zhang
Journal:  Hum Mutat       Date:  2019-12-03       Impact factor: 4.878

4.  Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy.

Authors:  Paula Triana-Fonseca; Juan Fernando Parada-Márquez; Claudia T Silva-Aldana; Daniela Zambrano-Arenas; Laura Lucia Arias-Gomez; Natalia Morales-Fonseca; Esteban Medina-Méndez; Carlos M Restrepo; Daniel Felipe Silgado-Guzmán; Dora Janeth Fonseca-Mendoza
Journal:  Appl Clin Genet       Date:  2021-10-01

Review 5.  Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Elahe Valipour; Mohsen Kazeminia; Reza Fatahian; Aliakbar Kiaei; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Orthop Surg Res       Date:  2022-02-15       Impact factor: 2.359

6.  Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences.

Authors:  Yanan Zhang; Joshua R Mann; Katherine A James; Suzanne McDermott; Kristin M Conway; Pangaja Paramsothy; Tiffany Smith; Bo Cai
Journal:  Neuroepidemiology       Date:  2021-01-21       Impact factor: 3.282

7.  Theragnosis for Duchenne Muscular Dystrophy.

Authors:  Leonela Luce; Micaela Carcione; Chiara Mazzanti; Paula I Buonfiglio; Viviana Dalamón; Lilia Mesa; Alberto Dubrovsky; José Corderí; Florencia Giliberto
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.